March 5, 2020 Scientific paper Useful tool Prostate

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy

Main author: Morton, G., McGuffin, M e.a.
More information
Return to overview